JP2023524133A5 - - Google Patents

Info

Publication number
JP2023524133A5
JP2023524133A5 JP2022567286A JP2022567286A JP2023524133A5 JP 2023524133 A5 JP2023524133 A5 JP 2023524133A5 JP 2022567286 A JP2022567286 A JP 2022567286A JP 2022567286 A JP2022567286 A JP 2022567286A JP 2023524133 A5 JP2023524133 A5 JP 2023524133A5
Authority
JP
Japan
Prior art keywords
ethyl
oxo
trifluoromethoxy
phenyl
triazine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022567286A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023524133A (ja
JP7697974B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2021/000304 external-priority patent/WO2021224680A1/en
Publication of JP2023524133A publication Critical patent/JP2023524133A/ja
Publication of JP2023524133A5 publication Critical patent/JP2023524133A5/ja
Application granted granted Critical
Publication of JP7697974B2 publication Critical patent/JP7697974B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022567286A 2020-05-08 2021-05-06 Gpr139アゴニストの置換ベンゾトリアジノン代謝物 Active JP7697974B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063021895P 2020-05-08 2020-05-08
US63/021,895 2020-05-08
PCT/IB2021/000304 WO2021224680A1 (en) 2020-05-08 2021-05-06 Substituted benzotriazinone metabolites of a gpr139 agonist

Publications (3)

Publication Number Publication Date
JP2023524133A JP2023524133A (ja) 2023-06-08
JP2023524133A5 true JP2023524133A5 (cg-RX-API-DMAC7.html) 2024-04-30
JP7697974B2 JP7697974B2 (ja) 2025-06-24

Family

ID=76624075

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022567286A Active JP7697974B2 (ja) 2020-05-08 2021-05-06 Gpr139アゴニストの置換ベンゾトリアジノン代謝物

Country Status (5)

Country Link
US (1) US12559465B2 (cg-RX-API-DMAC7.html)
EP (1) EP4146635A1 (cg-RX-API-DMAC7.html)
JP (1) JP7697974B2 (cg-RX-API-DMAC7.html)
CA (1) CA3177117A1 (cg-RX-API-DMAC7.html)
WO (1) WO2021224680A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI873185B (zh) 2019-09-16 2025-02-21 日商武田藥品工業股份有限公司 唑稠合之嗒-3(2h)-酮衍生物
JP7697974B2 (ja) 2020-05-08 2025-06-24 武田薬品工業株式会社 Gpr139アゴニストの置換ベンゾトリアジノン代謝物
CN116693545A (zh) * 2022-03-01 2023-09-05 上海科技大学 噻吩并含氮杂环类化合物、含其的药物组合物、其制备方法及其应用
CN116693536A (zh) * 2022-03-01 2023-09-05 上海科技大学 吡咯并三嗪酮类化合物、含其的药物组合物、其制备方法及其应用
CN121159462A (zh) * 2025-11-19 2025-12-19 杭州市第七人民医院(杭州市心理危机研究与干预中心) 喹唑啉酮类化合物及其在制备神经系统疾病药物中的应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3794726A (en) 1972-08-21 1974-02-26 Uniroyal Inc Inhibiting aggressive behavior with 1,2,3-benzotriazin-(3h)-one
ATE108791T1 (de) 1987-11-04 1994-08-15 Beecham Group Plc Neue 4-oxobenzotriazine und 4-oxochinazoline.
JP4079727B2 (ja) 2002-09-06 2008-04-23 セントラル硝子株式会社 光学活性1−(フルオロ、トリフルオロメチルまたはトリフルオロメトキシ置換フェニル)アルキルアミンn−モノアルキル誘導体とその製造方法
CA2526506A1 (en) 2003-06-09 2004-12-16 Boehringer Ingelheim International Gmbh Inhibitors of papilloma virus
EP1651643A4 (en) 2003-07-31 2008-10-08 Irm Llc BICYCLIC COMPOUNDS AND COMPOSITIONS USED AS PDF INHIBITORS
FR2875805B1 (fr) 2004-09-27 2006-12-29 Genfit S A Composes derives de n-(benzyl) phenylacetamide substitues, preparation et utilisations
UY30048A1 (es) 2005-12-23 2007-07-31 Astrazeneca Ab Derivados sustituidos de la n,2-(1h-benzimidazol-1-il) acetamida, composiciones farmacéuticas conteniéndolos, procesos de preparación y aplicaciones
TWI433839B (zh) 2006-08-11 2014-04-11 Neomed Inst 新穎的苯并咪唑衍生物290
AU2008345225A1 (en) 2007-12-21 2009-07-09 University Of Rochester Method for altering the lifespan of eukaryotic organisms
WO2011138265A2 (en) 2010-05-03 2011-11-10 Evotec Ag Indole and indazole derivatives as orexin receptor antagonists
EP2968240A2 (en) 2013-03-14 2016-01-20 Janssen Pharmaceutica, N.V. Physiological ligands for gpr139
JO3719B1 (ar) 2014-11-20 2021-01-31 Takeda Pharmaceuticals Co 4- أوكسو-4،3- داي هيدرو-3،2،1- بنزوترايازينات كمواد ضابطة لأجل gpr139
TWI873185B (zh) 2019-09-16 2025-02-21 日商武田藥品工業股份有限公司 唑稠合之嗒-3(2h)-酮衍生物
JP7697974B2 (ja) 2020-05-08 2025-06-24 武田薬品工業株式会社 Gpr139アゴニストの置換ベンゾトリアジノン代謝物
US20230310441A1 (en) 2020-09-21 2023-10-05 Takeda Pharmaceutical Company Treatment for schizophrenia

Similar Documents

Publication Publication Date Title
JP6392241B2 (ja) 3,5−ジアミノ−6−クロロ−n−(n−(4−フェニルブチル)カルバムイミドイル)ピラジン−2−カルボキサミド化合物
JP2021534124A5 (cg-RX-API-DMAC7.html)
JP2010508360A5 (cg-RX-API-DMAC7.html)
JP2013535460A5 (cg-RX-API-DMAC7.html)
CN105579035B (zh) 二巯基化物类粘液溶解剂
JP2024514010A5 (cg-RX-API-DMAC7.html)
CN105001165A (zh) 取代的二氨基嘧啶其组合物,和用其治疗的方法
RU2005100836A (ru) Производные пептидов, содержащие тиазепиновую группу, для лечения гиперлипемических состояний
JP2010508361A5 (cg-RX-API-DMAC7.html)
RU2008142834A (ru) Модуляция церамидкиназы
RU2013108702A (ru) Ингибиторы деметилазы lsd1 на основе арилциклопропиламина и их применение в медицине
RU2007124545A (ru) Производные [4-(гетероарил)пиперазин-1-ил]-(2,5-замещенный фенил)метанона в качестве ингибиторов переносчика глицина-1 (glyt-1) для лечения неврологических и психоневрологических заболеваний
NO20076219L (no) Farmasoytisk formulering med apomorfin for bukkal administrering
EA200601287A1 (ru) Производные (3-оксо-3,4-дигидрохиноксалин-2-иламино) бензамида и родственные соединения в качестве ингибиторов гликогенфосфорилазы для лечения диабета и ожирения
JP7650228B2 (ja) 官能化シクロオクテンを調製するためのプロセス
RS56717B1 (sr) Derivati dolastatina 10 i auristatina
JP2024525693A5 (cg-RX-API-DMAC7.html)
CN107708680A (zh) 新的二硫醇粘液溶解剂的前药
JP2010533131A5 (cg-RX-API-DMAC7.html)
RU2010145463A (ru) Производные замещенного 2-фенилпиридина
CN1482122A (zh) 用于制备2-硫代碳青霉烯的中间体
RU2015137298A (ru) Ингибиторы тирозинкиназы брутона
JP2022522890A5 (cg-RX-API-DMAC7.html)
RU2008128875A (ru) Аминное соединение и его применение в медицинских целях
KR101422299B1 (ko) (2r)-2-〔(4-설포닐)아미노페닐〕프로판아마이드 및 이들 화합물을 함유하는 약학 조성물